Symbol="IMVT"
AssetType="Common Stock"
Name="ImmunovantÂ Inc"
Description="Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. The company is headquartered in New York, New York."
CIK="1764013"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="REAL ESTATE & CONSTRUCTION"
Industry="BLANK CHECKS"
Address="412 W. 15TH STREET, FLOOR 9, NEW YORK, NY, US"
FiscalYearEnd="March"
LatestQuarter="2023-03-31"
MarketCapitalization="2941584000"
EBITDA="-208083008"
PERatio="None"
PEGRatio="None"
BookValue="2.781"
DividendPerShare="0"
DividendYield="0"
EPS="-1.68"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.282"
ReturnOnEquityTTM="-0.507"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.68"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="29.77"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="4.727"
EVToRevenue="-"
EVToEBITDA="-8.22"
Beta="0.931"
num_52WeekHigh="25.13"
num_52WeekLow="4.05"
num_50DayMovingAverage="20.88"
num_200DayMovingAverage="16.87"
SharesOutstanding="130563000"
DividendDate="None"
ExDividendDate="None"
symbol="IMVT"
open="22.57"
high="22.86"
low="22.17"
price="22.83"
volume="734723.00"
latest_trading_day="2023-07-31"
previous_close="22.53"
change="0.30"
change_percent="1.3316%"
aroon_positive_momentum_days="63"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="63"
Volume_recent_avg="1032194"
Change_recent_avg="0.01"
Delta_recent_avg="0.89"
Variance_recent_avg="0.45"
Change_ratio_recent_avg="-0.01"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="63"
Aroon_momentum_negative="37"
image_negative_thumbnail_id_1="1110"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0143.jpeg"
image_negative_thumbnail_id_2="140"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0036.jpeg"
image_neutral_thumbnail_id_1="591"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0008.jpeg"
image_neutral_thumbnail_id_2="576"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0023.jpeg"
image_positive_thumbnail_id_1="977"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0139.jpeg"
image_positive_thumbnail_id_2="958"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0120.jpeg"
image_professor_thumbnail_id_1="1169"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
